Eip Pharma

Developer of a novel kinase inhibitor to treat Alzheimer's Disease

placeCambridge, Massachusetts, United States calendar_todayFounded 2012 groups4 employees language eippharma.com

Registered entities

Innovation

12 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 682 times.

YearFilings
20151
20163
20174
20181
20195
20204
20213
20227
20233
20242
20252
20262

Investor mix

1 investor on record; lead investors include Access Industries.

Investor typeCountShare
Venture capital1100%
Coming soon